Search By:
Products
Injury
Topic
Company
Industry
Pfizer's estrogen replacement drug Provera may increase the risk of blood clots, stroke, heart attack and breast cancer.
Investigation Source
- Nationwide
Investigation Scope
Category Information
Investigation Topic
- Increased Risk of Bodily Injury
Product or Service
- Provera
Injury Types
- Blood Disorders and Clots
- Heart Attack
- Breast Cancer
- Stroke
Investigation Details
Provera manufactured by Pfizer is derived from the female hormone progesterone. The FDA approved Provera in 1959 and has been prescribed to millions of women. Provera is sometimes used with another medication (a type of estrogen) as combination hormone replacement therapy (HRT) in women after menopause. Women may be given Provera if their menstrual periods have stopped or a female hormone imbalance is causing their uterus to bleed abnormally. Provera is also prescribed to prevent abnormal growth of the uterine lining in women taking estrogen replacement therapy.
What are the dangers associated with Provera? Using Provera can increase your risk of blood clots, stroke, heart attack, or breast cancer. You should never take Provera during the first 4 months of pregnancy. During this formative period, even a few days of treatment with Provera might put your unborn baby at increased risk for birth defects.
Do not change medications without first consulting your doctor.
What are the dangers associated with Provera? Using Provera can increase your risk of blood clots, stroke, heart attack, or breast cancer. You should never take Provera during the first 4 months of pregnancy. During this formative period, even a few days of treatment with Provera might put your unborn baby at increased risk for birth defects.
Do not change medications without first consulting your doctor.
Defendant Details
| Name (Stock Symbol) | Brief Description |
|---|---|
| Pfizer Inc. (PFE) | Pfizer Inc. is a large pharmaceutical company. |